
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it
Israeli life sciences investment company listed on the Tel Aviv Stock Exchange, backing biotech ventures

Clal Biotechnology Industries is an Israeli investment company focused on life sciences, with shares traded on the Tel Aviv Stock Exchange. It finds science-based projects and guides them towards commercial results.
Holdings named on its site include MediWound, which works on burn and chronic wound care, Gamida Cell, Elicio, Cadent Therapeutics, eXIthera Pharmaceuticals and Biokine Therapeutics. It also lists Cactus Acquisition Corp 1, a special purpose acquisition company targeting Israel-related healthcare businesses.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-29. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Clal Biotechnology Industries.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Venture capital firm partnering with founders from first idea through to public listing

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

A diversified Indian financial-services group offering credit, asset management and insurance
Everything here links back to the same verified catalogue. Pick your next stop.